Parkinson's disease and related disorders--XVIII WFN World Congress.
The XVIII World Federation of Neurology (WFN) World Congress on Parkinson's Disease and Related Disorders, held in Miami, FL, USA, included topics covering new therapeutic developments in this field. This conference report highlights selected presentations on the pathophysiology and treatment of these diseases, including the design of neuroprotective compounds, protein inhibition in the absence of catechol-O-methyltransferase (COMT), evaluating the striatal distribution of COMT, clinical results for PYM-50028 (Phytopharm plc) and ProSavin, and research into the use of stem cell treatments for Parkinson's disease.
Grosset
Donald
D
Southern General Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK. d.grosset@clinmed.gla.ac.uk
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D002394:Catechol O-Methyltransferase / Q000235:genetics / Q000378:metabolism; D015195:Drug Design; D006801:Humans; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010300:Parkinson Disease / Q000503:physiopathology / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000379:methods*
D000978:Antiparkinson Agents; D018696:Neuroprotective Agents; D002394:Catechol O-Methyltransferase